Blincyto Blinatumomab Sales Up 48% In 2023 |
Feb-2024 |
Bispecific Antibodies Market Size Forecast USD 40 Billion By 2029 |
Feb-2024 |
Lunsumio Mosunetuzumab Sales Surpassed USD 65 Million In 2023 |
Feb-2024 |
Vabysmo Faricimab Sales Surpassed USD 2 Billion In 2023 |
Feb-2024 |
Global Bispecific Antibodies Market Size Market Forecast 2029 |
Feb-2024 |
Bicycle Toxin Conjugates Clinical Trials Bicycle Toxin Conjugate Research Bicycle Therapeutics Clinical Pipeline Report Insight |
Feb-2024 |
CD70 Targeted Therapies In Cancer |
Jan-2024 |
Cancer Antibody Combination Therapy |
Jan-2024 |
DLL3 Delta Like Lig& 3 As Emerging Target In Cancer Therapy |
Jan-2024 |
Combination Immunotherapy As Targeted therapy In Cancer |
Oct-2023 |
Multispecific Antibody Clinical Research Insight |
Oct-2023 |
Tetraspecific Antibodies Clinical Trials Therapeutic Development Insight |
Oct-2023 |
Clinical Significance Of TIGIT Immune Checkpoint Inhibitors Drugs |
Oct-2023 |
Clinical Trials In China |
Sep-2023 |
Top Pharmaceutical Companies in China |
Sep-2023 |
Blincyto Sales H1 2023 |
Aug-2023 |
Hemlibra Sales H11 2023 |
Aug-2023 |
Lunsumio Sales H1 2023 |
Aug-2023 |
Vabysmo Sales H1 2023 |
Aug-2023 |
Kimmtrak Sales H1 2023 |
Aug-2023 |
Epkinly Sales H1 2023 |
Aug-2023 |
Columvi Sales H1 2023 |
Aug-2023 |
FDA Approved Bispecific Antibodies Insight |
Aug-2023 |
Epkinly FDA Approval |
Aug-2023 |
Cancer Antibody Drug Conjugate Market Insight |
Aug-2023 |
Anti Cancer Peptide Drugs Market Clinical Trials Insight |
Aug-2023 |
Elrexfio FDA Approval For Refractory Multiple Myeloma |
Aug-2023 |
US FDA Approved Orphan Drugs Clinical Trials Insight |
Jul-2023 |
Orphan Drugs In United Sates |
Jul-2023 |
US Orphan Drugs Market Overview |
Jul-2023 |
Tetra Specific Antibodies Clinical Development Report |
Jun-2023 |
Controlled Release Drug Delivery Market Insight 2028 |
May-2023 |
Lumakras Sotorasib Sales USD 285 Million In 2022 |
May-2023 |
Next Generation Antibodies Market |
May-2023 |
Immunotherapy In Neurodegenerative Diseases |
May-2023 |
China Cancer Antibody Market Dominated By Local Companies |
May-2023 |
China Dominating NK Cell Therapy Clinical Development |
Apr-2023 |
CD137 Antibodies Clinical Trials Companies Approval Insight |
Apr-2023 |
Cadonilimab Tetravalent Bispecific Antibody Clinical Trials |
Apr-2023 |
Ivonescimab Bispecific Antibody Clinical Trials For Lung Cancer |
Apr-2023 |
Talquetamab T Cell Redirecting GPRC5D Bispecific Antibody |
Apr-2023 |
Glofitamab Clinical Trials For Diffuse Large B Cell Lymphoma |
Apr-2023 |
Sonodynamic Therapy For Cancer Treatment |
Apr-2023 |
TIL Therapy Clinical Trials Cost Companies Market Size Insight |
Apr-2023 |
Roche T Cell Engager Bispecific Antibody Approved In Canada |
Mar-2023 |
Tumor Infiltrating Lymphocytes TIL Therapy Clinical Trials Market Size Companies Insight |
Mar-2023 |
Tetraspecific Antibodies Proprietary Technologies Insight |
Mar-2023 |
Tetraspecific Antibody Emfizatamab Anticipated Approval |
Mar-2023 |
Emerging NK Cell Therapy Market Companies Clinical Trials Outlook |
Feb-2023 |
Targeting Delta Like 3 DLL3 in Cancer Immunotherapy |
Feb-2023 |
PARG Protein As Novel Target For Targeted Drug Development |
Feb-2023 |
Protein Folding Chaperone BiP As Molecular Target For Immunotherapy |
Feb-2023 |
B7H3 Targeted Antibody Drug Conjugate Clinical Trials Insight |
Feb-2023 |
Spleen Tyrosine Kinase Inhibitor Drugs Clinical Trials Insight |
Feb-2023 |
Anti TIM3 Antibody Cancer Immunotherapy Clinical Trials Market |
Feb-2023 |
CD276 As Cancer Immunotherapy Target |
Feb-2023 |
Next Generation Immune Checkpoint Inhibitors |
Feb-2023 |
Anti LAG 3 Antibody Clinical Trials Shows Promising Outcomes |
Feb-2023 |
Antibody Drug Conjugates Dominating Clinical Trials Targeting CD276 |
Feb-2023 |
Booming China Bispecific Antibody Market |
Feb-2023 |
Bispecific Antibodies Sales USD 5 Billion 2022 |
Feb-2023 |
Lunsumio Sales USD 3 Million In 2022 |
Feb-2023 |
Hemlibra Sales USD 4 Billion In 2022 |
Feb-2023 |
Rare Diseases Market Clinical Pipeline Forecast 2028 |
Feb-2023 |
Crovalimab Shows Positive Results in Phase III Trial for Rare Life Threatening Blood Disorder |
Feb-2023 |
Rapidly Exp&ing Global Bispecific Antibody Market |
Feb-2023 |
Targeting LAG-3 CD223 In Cancer Immunotherapy |
Feb-2023 |
Oncolytic Virus Therapy Market Size Companies Clinical Trials Report 2028 |
Feb-2023 |
Emergence Of Anti TIGIT Antibodies Immunotherapy |
Feb-2023 |
LAG-3 Emerging As Next Generation Immune Checkpoint Inhibitor Immunotherapy |
Feb-2023 |
Blincyto Blinatumomab Sales Increase To USD 583 Million In 2022 |
Feb-2023 |
Vista Inhibitors As Emerging Therapeutic Approach in Clinical Trials |
Jan-2023 |
STAT3 As Target For Cancer Immunotherapy |
Jan-2023 |
Role Of Combination Therapy Strategies in Breast Cancer |
Nov-2022 |
Emergence of Combination Cancer Therapy As New Targeted Approach |
Oct-2022 |
Emergence of Tetra Specific Antibody In Targeted Therapy |
Oct-2022 |
Antibodies Leading The Combination Cancer Immunotherapy Market |
Jun-2022 |
KRAS Inhibitors Market Clinical Research c Sotorasib Sales Report 2028 |
Jun-2022 |
Global Bispecific Antibody Market Size Sales USD 3600 Million In 2021 |
Apr-2022 |
Multispecific Antibody Development For Cancer Immunotherapy |
Apr-2022 |
Multispecific Antibody Targeted Cancer Therapy Market Clinical Development Insight 2028 |
Apr-2022 |
LAG3 Inhibitor Market Size Clinical Trials Forecast |
Feb-2022 |
Global Orphan Drug Market Size Clinical Trials Opportunity Insight |
Feb-2022 |
Global Cell Therapy Clinical Trials Market Size Insight |
Jan-2022 |
This is a test 2 |
Nov-2021 |
TIGIT Inhibitor Drug Clinical Trials Research And Role In Cancer Immunotherapy |
Nov-2021 |
Multispecific Antibodies Clinical Research Status & Market Opportunity |
Nov-2021 |
FDA Approved Bispecific Antibodies For Targeted Cancer Therapy |
Nov-2021 |
TST001 Wins US FDA Orphan Drug Designation |
Sep-2021 |
FDA Approve Peptide Drug Conjugate Antibody To Witness Positive Outlook In Future |
Apr-2021 |
Angiotensin II Receptor Blocker Drug to Boost the Potential of PD-1 Inhibitor Immunotherapy |
Dec-2020 |
Novel Research Study Inclined towards Ending SARS-CoV-2 P&emic |
Dec-2020 |
Role of Weight Loss Surgery in Tpe-2 Diabetes |
Nov-2020 |
Study Found Early Diagnosis Method for Type-2 Diabetes |
Nov-2020 |
Study Found Real Time Analysis of Type-2 Diabetes |
Nov-2020 |
Role of Oral Semaglutide in type-2 Diabetes from Managed Care Perspective |
Nov-2020 |
Study have Found Genes which Promote Glioblastoma Invasiveness |
Nov-2020 |
Encouraging Results of Tesetaxel in Patients with Metastatic Breast Cancer |
Nov-2020 |
Novel Gene Therapies for Rare Diseases in Development |
Nov-2020 |
Novel Adenovirus Gene in Placental Insufficiency |
Nov-2020 |
New Approach to Map Genetic Network by Using CRISPR Technology |
Nov-2020 |
CRISPR-LIGHT- Novel Technology in Brain Organoids |
Nov-2020 |
Revolution in Managing Type-1 Diabetes by Monitoring Device |
Nov-2020 |
Gene Therapy Application to Transform Vision Treatment in Mice Model |
Nov-2020 |
Personalized Medicine to Thrive the Entire Cancer Therapeutics Market in Future |
Nov-2020 |
Blenrep Drug to Undo Certain Changes Performed by Multiple Myeloma Cancer in Patients |
Nov-2020 |
Targeting Adrenomedullin Hormone to Significantly Improve Life Expectancy in Patients Suffering from Different Cancer Types |
Nov-2020 |
PCLX-001 to Help Researchers to Reduce the Growth of Cancer Cells in Blood Cancer |
Nov-2020 |
Chemotherapy – Nivolumab Combination to Improve the Overall Survival Rate in NSCLC Patients |
Nov-2020 |
Tecentriq Injection to Overpower Ability of Cells to Outgrow in Non-Small Cell Lung Cancer |
Nov-2020 |
Atezolizumab to be Involved in Increasing the Pathological Complete Response Rate in Triple-Negative Breast Cancer |
Nov-2020 |
CRISPR -Cas9 to Emerge as Novel Therapeutic Treatment for Myotonic Dystrophy Disease |
Nov-2020 |
CPMV to get Corrected by Introducing Immunotherapy Treatment in Dogs & Mouse Model |
Nov-2020 |
Researchers Inclined towards Developing Next-Generation Antibodies for Cancer Treatment |
Nov-2020 |
EphA2 to Drive Resistance against BRAF Inhibitors in Melanoma Patients |
Nov-2020 |
Trio Combination of CDK4/6, MEK & RABL64 to Drive the Cancer Therapeutics Market |
Nov-2020 |
MEK & BET Inhibitors to Improve the Cancer Treatment Parameters at High Rate |
Nov-2020 |
Nanoparticle Delivery System Boosting the Treatment Efficacy in Melanoma Patients |
Nov-2020 |
BRAF & MEK Inhibitor Drugs to end the Resistance Developed by the Melanoma Patients |
Nov-2020 |
Improved Complete Response in the Patients Injected with Atezolizumab |
Nov-2020 |
CD8+ & CD4+ T Cells Neoantigens Research Work to Boost the Overall Cancer Vaccine Market |
Nov-2020 |
Researchers Focused towards Novel Cancer Vaccine to Stop Cancer Cells from Re-growing |
Nov-2020 |
Researchers to Classify Neoantigens as Novel Therapeutic Regimen for Cancer Patients |
Nov-2020 |
Identification of Novel Genes Important for Immune System Escape by Cancer Cells Using CRISPR |
Nov-2020 |
Immune Checkpoint Inhibitors Combination to Control the Division of Cancer Cells in Bladder |
Nov-2020 |
Next Generation ALK Inhibitors to Improve the Life of Patients having ALK-Positive NSCLC |
Nov-2020 |
Osimertinib to Overcome the Challenge of Developing Resistance in the Patients Suffering from NSCLC |
Nov-2020 |
Sintilimab & Bevacizumab Injection to Deliver Promising Results in the Treatment of Advanced Heptacellular Cancer |
Nov-2020 |
Novel NRXN1 Therapeutic Target in ADC for Small Cell Lung Cancer |
Nov-2020 |
Radioimmunotherapy Drug to Boost the Activity of Rituximab in Non-Hodgkin Lymphoma Patients |
Nov-2020 |
Novel Design of Nanotechnology to Deliver Promising Result in the Treatment of Cancer |
Nov-2020 |
CDK7 Inhibitors to Play Promising Role in Controlling Uncontrollable Division of Cancer Cells |
Nov-2020 |
Androgen Receptor Inhibitor to Provoke Better Survival Response in Metastatic Castration-Sensitive Prostate Cancer |
Nov-2020 |
Lorlatinib to Deliver High Response Rate in the Lung Cancer Patients |
Nov-2020 |
Novel BRAF Inhibitor Drugs to Overcome Challenges of First Generation BRAF Inhibitor Drugs |
Nov-2020 |
Dietary Supplements of Vitamin B3 to Improve the Efficacy of Immunotherapy Drugs |
Nov-2020 |
Combination Drugs to Boost Clinical Outcomes for Advanced Kidney Cancer Treatment |
Nov-2020 |
Biomarkers to Reveal Response Rate in Patients when Given Immune Checkpoint Inhibitor Drugs |
Nov-2020 |
University of Michigan Researchers to Develop Potent Small Molecule Inhibitors for Cancer Treatment |
Nov-2020 |
Different Targeted Therapies Evolving Faster than any other Traditional Therapy for Lung Cancer |
Nov-2020 |
Selpercatinib to Show Durable Response in Lung Cancer & Thyroid Cancer Treatment |
Nov-2020 |
Immune Checkpoint Inhibitors to Increase Cardiovascular Diseases in the Patients |
Nov-2020 |
Combinational Impact of HDAC & mTOR Associated with Promising Results |
Nov-2020 |
Researchers Inclined towards Optimizing Novel BRAF Inhibitors against Advanced Cancers |
Nov-2020 |
Phase II Clinical Research Exp& the Applications of Ipilimumab & Nivolumab in Prostate Cancer Patients |
Nov-2020 |
Combinational Therapy to Overcome Refractory Hodgkin Lymphoma Challenges at Global Level |
Nov-2020 |
Novel PARP Inhibitors Boosting the Activity of Chemotherapy & Radiation Therapy |
Nov-2020 |
Bladder Cancer to get Evaluated for Proton Pump Inhibitors |
Nov-2020 |
Colorectal Cancer Patients to Receive Potent PDE5 Inhibitors as an Effective Treatment |
Nov-2020 |
Nanobiologics & Immunotherapy to Evolve the Entire Cancer Therapeutics 180 Degrees |
Nov-2020 |
Immune Checkpoint Inhibitor Combination with Chemotherapeutic Drug to Improve the Overall Survival Rate of Breast Cancer Patients |
Nov-2020 |
Clinical Study Indicates towards Progressive State of Selpercatinib against Medullary Thyroid Cancer |
Nov-2020 |
Novel Model to Accurately Predict the Response Generated by Immunotherapy in Lung Cancer |
Nov-2020 |
TRIM37 Overexpression & PLK4 Inhibitor to Come up as Novel Breast Cancer Treatment Regimen |
Nov-2020 |
MIT Researchers to Uncover More Potent Version of Kl-Arv-03 against Prostate Cancer Cell Lines |
Nov-2020 |
Multi-Valent Targeting by CAR-T Cell Therapy Emerging as Novel Multiple Myeloma Treatment |
Nov-2020 |
Autism Spectrum Disorder Treatment Supported by Novel Stem Cell Therapy & Educational Intervention |
Nov-2020 |
Stem Cell Combination Therapy with Enzyme Inhibitors Leading towards Declined Rate of Heart Attacks |
Nov-2020 |
Induced Trophoblast Stem Cells to Treat Pregnant Ladies with Placental Problems |
Nov-2020 |
Stromal Cell Therapy to get Recognized as Emerging anthracycline-Induced Cardiomyopathy Treatment |
Nov-2020 |
CAR-T Cell Therapy & Oncolytic Virus Therapy to be Safe & Effective in the Solid Cancer Patients |
Nov-2020 |
Myocardial Infraction Clinical Trial Study to Observe Obstacles in Future Years |
Nov-2020 |
ICANS to have no Impact on the Overall Survival in Lymphoma Patients |
Nov-2020 |
Gene T cell Therapy to Emerge as a Novel Treatment Regimen for Epithelial Cancers |
Nov-2020 |
Combinational Therapy to Overcome High Mortality Rate in HR+, HER2- Breast Cancer |
Nov-2020 |
Trispecific Cancer Antibody Therapy Market Insight |
Nov-2020 |
Celyad Biosciences to Improve CAR-T Cell Therapy by the Introduction of shRNA |
Nov-2020 |
Emerging Computational Model to Accelerate Therapeutic Applications |
Nov-2020 |
Novel Cell Therapy Design to Improve the Persistence of the Cells inside the Inflammatory Bowel Disease Patient |
Nov-2020 |
Novel Stem Cell Therapy to get Recognized as Efficient Parkinson’s Disease Treatment |
Nov-2020 |
Novel CAR-T Cell Therapy Development against Metastatic Rhabdomyosarcoma in a Patient |
Nov-2020 |
CAR-T Cell Therapy to get Evaluated for Hidden Applications in Case of Hematogical Malignancies |
Nov-2020 |
Stem Cell Therapy as an Emerging Novel Therapeutic Facility for Patients |
Nov-2020 |
Novel CAR-T Cell Combination Regimen to Overcome Resistance Challenge for Mantle Cell Lymphoma |
Nov-2020 |
T-Cell Therapy Vs. Vaccine for the Treatment of Covid-19 Patients |
Nov-2020 |
CAR-T Cell Therapy with Radiation Therapy to Deliver Promising Results in Patients Suffering from Multiple Myeloma |
Nov-2020 |
Atara Biotherapeutics Received Approval for Clinical Phase 1 Clinical Trial for CAR-T Cell Therapy for Mesothelioma Patients |
Nov-2020 |
SMART Microcarriers to Enhance the Treatment Rate in the Global Therapeutics Sector |
Nov-2020 |
Clinical Stage Data Presented by Kiadis Biotherapeutics for Lung Cancer |
Nov-2020 |
Lou Gehrig’s Disease to Receive Novel Cell Therapy as a Promising Treatment |
Nov-2020 |
Circulating Tumor Cells to get Identified before the Progression of Breast Cancer in the Patients |
Nov-2020 |
Novel Emerging Microneedle Market for Painless Delivery of Drugs |
Nov-2020 |
Opioid Dependency to get Treated with SL-BUP & XR-BUP Introduction into the Patients |
Nov-2020 |
Novel Gene Therapy Market to Introduce Microneedle Market for Boosting the Treatment Effectiveness |
Nov-2020 |
Dendritic Cell Vaccine Causing the Strengthening of Immune System in Alzheimer’s Disease |
Nov-2020 |
Small Molecule & Protein Interaction to Become Novel Therapeutic Target for Alzheimer’s Disease |
Nov-2020 |
PEG Layered Nanoparticles to Cross Blood Brain Barrier for Efficient Delivery of the Parkinson’ Disease Drugs |
Nov-2020 |
Covid-19 Impact on CAR-T Cell Therapy Clinical Trial for the Patients Suffering from DLBCL |
Nov-2020 |
Infused Vesicles to get Recognized as Novel Therapeutic Treatment for Multiple Sclerosis 02-Dec |
Nov-2020 |
Netrin-G Blocking to Effectively Emerge as Novel Pancreatic Cancer Treatment |
Nov-2020 |
Immunotherapy Effective Results with respect to Cervical Cancer Pseudoprogression Events |
Nov-2020 |
AMG-509 Targeting Prostate Cancer Patients Expressing STEAP1 Protein |
Nov-2020 |
Cancer Treatment to get a Novel Immunotherapy Drug C&idate |
Nov-2020 |
Novel Monoclonal Antibody Therapy Meeting the Needs of Non-Small Cell Lung Cancer Patients |
Nov-2020 |
Monoclonal Antibodies to Emerge as a Novel Treatment against Covid-19 Soon |
Nov-2020 |
Ibalizumab Boosting the Body’s Immune Response against HIV |
Nov-2020 |
TJ210/MOR210 Successful Clinical Research Outcomes in Immunology Market |
Nov-2020 |
Novel Monoclonal Antibody Efficiency in Treating Multiple Myeloma |
Nov-2020 |
Monoclonal Antibody to get Considered as Novel Therapeutic Treatment Regimen for Covid-19 Patients |
Nov-2020 |
Pancreatic Cancer Treatment with Novel ADC Immunotherapy Strategy |
Nov-2020 |
Evinacumab Monoclonal Antibody to Reduce the Chance of Cardiovascular Diseases in Patients |
Nov-2020 |
Hyperactivity Disorders in Adults Controlled with Long Acting Stimulants |
Nov-2020 |
Dapagliflozin & Exenatide to Improve Health Conditions in Patients Suffering from Type 2 Diabetes |
Nov-2020 |
Antibody Market to get Visualized as Potent Therapy against Viruses |
Nov-2020 |
CT-P59 to Recover Patients Suffering from Covid-19 |
Nov-2020 |
Nanoparticle & Desired Drug to Cross the Blood-Brain Barrier in case of Neurodegenerative Diseases |
Nov-2020 |
Researchers Pushing the Therapeutics Industry by Introducing Microrobots to the Sector |
Nov-2020 |
Microrobots to make Therapeutic Challenges with Treating Colon Disease to Decline |
Nov-2020 |
Nanoparticles Delivers Promising Results in Developing Anti-Cancer Activity |
Nov-2020 |
GPCR & RTK Targeting by Anti-Depressant Drug for Sarcoma in Children |
Nov-2020 |
Researchers Inclined towards Incorporating Riboswitches in Therapeutics Industry |
Nov-2020 |
Novel Technology to get Prominent Fame in the Overall Therapeutics Industry |
Nov-2020 |
Theragrippers Changing Drug Release Industry by its Promising Activities |
Nov-2020 |
John Hopkins University Researchers to Advance the Theragrippers Potential in Delivering Drug |
Nov-2020 |
Novel Gold Nanoparticle Technique Introduction to Study the Small Molecule Drug Dynamics in Real Time |
Nov-2020 |
Novel Drug Like Molecules Acting as Innovative Approach for Alzheimer’s Disease |
Nov-2020 |
Cysteine Rich Protein Extracted from Beetroot to be Highly Beneficial for Treating Neurodegenerative & Auto-Immune Diseases |
Nov-2020 |
Covid-19 Symptoms Management by Investigational Drug Brilacidin |
Nov-2020 |
HSV-1 Therapeutic Treatment Effectiveness in Treating Solid Cancer |
Nov-2020 |
CARG-2020 Expected to Show Promising Results in Case of Ovarian Cancer |
Nov-2020 |
Bacterial Virus to Manipulate Gut Microbiome |
Nov-2020 |
Microbiome Regulating Various Brain Disorders in the Patients |
Nov-2020 |
Autism Spectrum Disorder Treatment by Controlling Gut Microbiome |
Nov-2020 |
Immunotherapy Drugs Combination Holds Potential against Declining Lung Cancer Mortality Rate |
Nov-2020 |
Identification of Tumor Targeting Cells Done Correctly by Novel FucoID Approach |
Nov-2020 |
Kv1.3 Targeting Delivers Relief in the Mice Model Suffering from Lupus Nephritis |
Nov-2020 |
Metastatic Melanoma Patients Showing Durable Response with BEMPEG & Nivolumab Combination |
Nov-2020 |
CD8+ Cell Expression Linked with Improved Survival Rate in Prostate Cancer |
Nov-2020 |
Kv1.3 Targeting Delivers Relief in the Mice Model Suffering from Lupus Nephritis |
Nov-2020 |
Combinational Therapy to Boost the Market Size of Melanoma Cancer Market |
Nov-2020 |
Novel Oral Class of Drug More Beneficial than CAR-T Cell Therapy for DLBCL Patients |
Nov-2020 |
Inclination of the Researchers for Overcoming Osimertinib Resistance in NSCLC Patients |
Nov-2020 |
Quantitative Assay for Immune Checkpoints Impacting the Overall Immunotherapy Market |
Nov-2020 |
CTLA-4 Expression Linked With High Survival Rate by Checkpoint Inhibitor Therapy in Renal Cancer |
Nov-2020 |
Immune Checkpoint Inhibitors & TILs to Show Effectiveness against Angiosarcoma |
Nov-2020 |
KRAS Gene Mutation Targeted by Researchers for Wide Variety of Cancers |
Nov-2020 |
Tri-Specific Antibodies Effective against HIV Strains in Monkeys |
Nov-2020 |
Super-Engineered Antibodies as Novel Emerging Therapy against HIV |
Nov-2020 |
ICMR Researchers Identify BCG as a Protection Shield Over the Spread of Covid-19 |
Nov-2020 |
Novel CAR-T Cell Therapy Studied for its Effectiveness in the Treatment of Prostate Cancer |
Nov-2020 |
Sertraline Showing Promising Anti-Tumor Activity in Cancer Patients |
Nov-2020 |
Glioblastoma to Receive Novel Personalized Cancer Vaccine |
Nov-2020 |
Addition of Two Components to Activate More Immunogenic Response against Melanoma |
Nov-2020 |
Novel Combination Techniques to Overcome Cost-Effective Challenge in Breast Cancer Treatment |
Nov-2020 |
Cervical Cancer Market to Experience Novel Combination Therapy Soon |
Nov-2020 |
Scaffolding Leading to Decline in the Breast Cancer Recurrence Rate in the Patients |
Nov-2020 |
RELA to get Considered as Novel Potential Therapy Option for Brain Cancer |
Nov-2020 |
Emerging Cell Transfer Therapy for the Treatment of Patients Suffering from Solid Cancers |
Nov-2020 |
Novel ADC Technology to Increase Pancreatic Cancer Therapeutics Market by Substantial Rate |
Nov-2020 |
3D Ultramicroscopy to Indulge itself with Better Resolution of Cancer Microenvironment |
Nov-2020 |
Promising Therapy Options for Controlling High Grade Risk of Non-Muscle Invasive Bladder Cancer Patients |
Nov-2020 |
Nanobiologics to Improve Trends & Opportunities for Cancer Patients |
Nov-2020 |
Epigenetic Regulation Study for Controlling Growth of Prostate Cancer Cells |
Nov-2020 |
Novel BITE Technology Expressing Positive Impact on Prostate Cancer Patients |
Nov-2020 |
Newly Discovered Fusion Proteins for Targeting Cancer |
Nov-2020 |
STAT3- Nanotechnology Targeting for Improving Mortality Rate for Aggressive Brain Cancer |
Nov-2020 |
FLX475 & Pembrolizumab to Exp& the Cancer Therapeutics Market at Global Level |
Nov-2020 |
Breast Cancer Treatment to get Targeted by the Researchers from the University of Sussex |
Nov-2020 |
Aldehyde Dehydrogenase- as a Novel Target for Increasing the Efficacy of Cancer Treatment |
Nov-2020 |
Chemotherapy & Immunotherapy to Boost Effectiveness for Triple-Negative Breast Cancer Treatment |
Nov-2020 |
Cancer Treatment to get Adjoined with Novel Nanotechnology for Better Efficiency |
Nov-2020 |
FLASH-RT to Overcome Challenges of Old Radiation Therapy After Effects |
Nov-2020 |
CR3022 Showing Positive Affinity for SARS-CoV-2 Treatment |
Aug-2020 |
Screening, Testing & Treatment of Cancer Patients Affected by Covid-19 P&emic |
Aug-2020 |
Promising Drug Effective against Brain Cancer |
Aug-2020 |
Positive Opinion for CRYSVITA by European Medicines Agency for the Treatment of X-Linked Hypophosphataemia |
Aug-2020 |
Turning Cancer Treatment to fight Covid-19 Patients |
Aug-2020 |
Rucaparib to Show Promising Results for the Prostate Cancer Patients |
Aug-2020 |
Convalescent Plasma to Statistically Upregulate Survival Rate of Covid-19 Infected Patients |
Aug-2020 |
Immunotherapy as an Extended Valuable Weapon against Breast Cancer Cells |
Aug-2020 |
Prostate Cancer Patients to Show Promising Results to Pembrolizumab/Chemo Regimen |
Aug-2020 |
Temelimab to Show Promising Early Clinical Trial Results for Auto-Immune Disorders |
Aug-2020 |
CAR & NK Cells to Work Effeciently against Cancer Cells |
Aug-2020 |
Whole-Brain Radiation Therapy Vs. Stereotactic Radiosurgery Analysis for Brain Metastasis |
Aug-2020 |
Pembrolizumab Combo Extends Chemotherapy Benefit in Pancreatic Cancer |
Aug-2020 |
Immune-Related Adverse Events Associated with Immunotherapy Treatment Regimen |
Aug-2020 |
Novel Points Identification for Treating Blindness – Retina Deattachment |
Aug-2020 |
Scientists Identifies Immunotherapy as a Potential Treatment for Pancreatic Tumors |
Aug-2020 |
Immunotherapy Protecting the Brain Cells from Aggressive Damage |
Aug-2020 |
Repatha Shows Promising Activity against Low-Density Lipoprotein Cholesterol & Cardiovascular Events |
Aug-2020 |
LEFTY1 Fueling the Success Rate of Breast Cancer Treatment Success |
Aug-2020 |
Phosphatase Cascade Offering Promising Results for Different Cancer Indications |
Aug-2020 |
CAR-T Cells Identifies Hodgkin’s Lymphoma Cells as Novel Target |
Aug-2020 |
Recent Advances in the Treatment Leading to Decline in the Overall Lung Cancer Mortality Rate |
Aug-2020 |
Novel Immunotherapy Combination Therapy for Advanced Skin Cancer |
Aug-2020 |
FT819 CAR T-cell Therapy Approved for Leukemia & Lymphome Clinial Trials |
Aug-2020 |
Intensity-Modulated Radiotherapy, 3-Dimensional Conformal Radiotherapy, or Proton Beam Radiotherapy Analysis for Second Cancer Diagnosis Risk |
Aug-2020 |
Two Cutting-Edge Technologies to Guide Through Cancer Treatment Decisions Entering Legal Implications |
Aug-2020 |
AURKB Protein to Control Idiopathic Pulmonary Fibrosis in Mice Model Organsims |
Aug-2020 |
Proteins Showing Promising Results towards Increasing the Effectiveness of the Immunotherapy Drugs |
Aug-2020 |
Baseline Circulating Tumor DNA Association with Immunotherapy Drugs |
Aug-2020 |
Identification of the Genes Allowing the Cancer Cells to Enter Brain Cells |
Aug-2020 |
Kidney Cancer Treatment Acclerated with Personalized Treatment & Genome Analysis Tool |
Aug-2020 |
Molecular Imaging Exam Approaching Personlaized Cancer Treatment |
Aug-2020 |
Manipulating the Survival Parameters of Cancer Cells |
Aug-2020 |
Experts from Abcam & Cancer Research United Kingdom to design Novel Cancer Therapies |
Aug-2020 |
NK Cell-Directed Immunotherapies Preventing Breast Cancer Metastasis |
Jul-2020 |
Empowering the Prostate Cancer Cells against Achieving Therpay Resistance |
Jul-2020 |
MBNL1/JNK Protein Targeted for Preventing Certain Cancer Relapse |
Jul-2020 |
Targeting the Cancer Specific Sites with Novel Light Activated CAR-T Cell Immunotherapy |
Jul-2020 |
Targeting Highly Immunogenic Tumor‐Associated Antigen (WT1) Overexpressed in all Major Types of Cancers |
Jul-2020 |
Combination of Hormone Therapy & Fasting-Mimicking Diet Promoting Breast Cancer Treatment |
Jul-2020 |
Spermine Synthase (SMS) Support Novel Insights about Colorectal Cancer Growth |
Jul-2020 |
Study Suggests a Lean Step Towards Breast Cancer Personalized Treatment |
Jul-2020 |
Azacytidine to Work Efficiently in the Absence of BRCA Mutation in Various Cancer Types |
Jul-2020 |
Nanoparticles & Two-Immune Boosting Drugs to Extend the Survival Time of Mice with Breast Cancer |
Jul-2020 |
Sequencing of Checkpoint Blockade Treatment to Optimize Hodgkin Lymphoma |
Jul-2020 |
Metabolic Pathway Targeted for More Effective Radiation Results in Glioblastoma |
Jul-2020 |
GRL-0617 Approach towards Controlling the Covid-19 P&emic Situation |
Jul-2020 |
Gut Microbiome Responsible for Halted Growth in Children |
Jul-2020 |
Novel Drug Target Discovery for Glioblastoma in the Patients |
Jul-2020 |
Diabetes Mellitus Treatment Getting Along Postively with Novel Drug C&idates |
Jul-2020 |
Pancreatic Ductal Adenocarcinoma Cells Storing Cholesterol Halted Cancerous Cell Growth |
Jul-2020 |
Cancer Patients Benefitted from Hot Chemotherapeutic Targeted Offers |
Jul-2020 |
Precision Medicine to go Along with the Treatment of Prostate Cancer |
Jul-2020 |
Unraveling of Tumor Microvenvironment by Imaging Through Nan-Radiomics |
Jul-2020 |
Drivers for Regulating Precision Medicines in Cancer Treatment |
Jul-2020 |
Regulation of Immune System by SP-2577 against Ovarian Cancer Cells |
Jul-2020 |
Detection of TP53 Mutation in HPV-Negative Vulvar Cancers |
Jul-2020 |
Multiple Myeloma Treatment Modified with another NK Cell Therapy |
Jul-2020 |
Covid-19 Prognosis Impacted by Ongoing Cancer Treatment in the Patients |
Jul-2020 |
RLS-0071 to Receive US FDA Clearance for Covid-19 P&emic |
Jul-2020 |
FACT-8D’s Validity & Responsiveness shows Promising Results for Cancer Treatment Trials |
Jul-2020 |
Magnetite-Gold Nanohybrids Discovery by Russian Researchers for Cancer Indications |
Jul-2020 |
RLS-0071 to Receive US FDA Clearance for Covid-19 P&emic |
Jul-2020 |
Mavacamten US FDA Approval for the Treatment of Symptomatic, Obstructive Hypertrophic Cardiomyopathy |
Jul-2020 |
RECIST Response Tested for First TC-210 in Advanced Mesothelin – Expressing Solid Tumors |
Jul-2020 |
Imbruvica & Rituximab Combination given a Positive Response from European Medicines Agency (EMA) for the Treatment of Chronic Lymphocytic Leukaemia (CLL) |
Jul-2020 |
CRISPR Cas9 Gene Editing Market Presents USD 2 Billion Market Opportunity |
Jan-2020 |
Cancer Tumor Organoids To Transform Cancer Therapy Market With USD 400 Million Opportunity |
Jan-2020 |
Cancer Organoid Approach To Drive Personalized Cancer Drug Development |
Jan-2020 |
Cancer Organoid Approach for Transforming Human Cancer Modeling |
Jan-2020 |
Cancer Organoid Modeling Offers USD 400 Million Opportunity |
Jan-2020 |
Tumor Organoids to Drive Personalized Cancer Treatment Market |
Jan-2020 |
US Fecal Microbiota Transplant Market – Rapidly Exp&ing Segment of Healthcare Sector |
Oct-2019 |
Indian Breast Pump Market Witnessing Exponential Growth |
Oct-2019 |
Cancer Stem Cell Therapeutics An innovative Approach for Cancer Treatment |
Oct-2019 |
CAR T-Cell Therapy Market – Emerging Leader of Immuno Oncology |
Oct-2019 |
IKS01 – A Lead ADC Shows Effectiveness in Tumor Regression |
Oct-2019 |
Pegilodecakin & Checkpoint Inhibitors Combo shows Prominent Action in NSCLC & Kidney Cancer |
Oct-2019 |
Opdivo Enhances the Overall Survival of Patients with Esophageal Cancer |
Oct-2019 |
Immunotherapy of Melanoma is Associated with B Cells |
Oct-2019 |
Two Dose HPV Vaccination schedule can Provide Long Term Immunogenicity |
Oct-2019 |
Topical Immunotherapy can Control Skin Cancer |
Oct-2019 |
AGI 134 Second Part of Phase 1/2 Study is initiated for Solid Tumor Management |
Oct-2019 |
New Long Acting Implants for HIV Drug Delivery |
Oct-2019 |
New Microcapsules Can Provide Safe & Effective Bimolecular Drug Delivery |
Oct-2019 |
Keytruda – Merck’s Checkpoint Inhibitor Got Approval as Monotherapy in China |
Oct-2019 |
Innate Pharma’s IPH5401 With Durvalumab shows Prominent Action in Phase I Trial Against Solid Tumor |
Oct-2019 |
Preclinical Data of BiCKI® shows promising action in Tumor Resistance |
Oct-2019 |
Anakinra – A new Therapeutic For Autoimmune Associated Cytokine Storm |
Oct-2019 |
IL-36 can control Blood Sugar Level |
Oct-2019 |
Fate Therapeutics Initiated cGMP for iPSC Derived Cell Therapies |
Oct-2019 |
Brentuximab Vedotin – Highly Effective Therapeutic for Hodgkin’s Lymphoma |
Oct-2019 |
BCG Vaccination Can Reduce the Probability of Lung Cancer |
Oct-2019 |
Glenmark’s GBR-1342 Get Orphan Drug Designation |
Oct-2019 |
Phase III Data of Blinatumomab Shows Prominent Activity in Pediatric Leukemia |
Oct-2019 |
Coxsackievirus - A Common Cold Virus Can Treat Bladder Cancer |
Oct-2019 |
TG4001 & Avelumab Combo Shows High Efficacy against HPV-Positive Cancer |
Oct-2019 |
Combo of Precision Vaccine & Maintenance Therapy Shows Prominent Action in Phase 1/2 Trial against Colorectal Cancer |
Oct-2019 |
World’s First Chlamydia Vaccine Got Success in Phase I Trial |
Oct-2019 |
CRISPR Can Enhance the Hybridoma Technology |
Oct-2019 |
Roche’s Tecentriq Shows Prominent Action against Advanced Bladder Cancer in Phase III Trial |
Oct-2019 |
Antibiotics can Reduce Checkpoint Inhibitor’s Activity |
Oct-2019 |
APVO603 - A New Adaptir™ Bispecific Antibody against Solid Tumors |
Oct-2019 |
New Combo to Boost KAS Inhibitors Activity Against Lung Cancer |
Oct-2019 |
A New Single Therapy Shows Positive Activity against Various Cancer Forms |
Sep-2019 |
PARP Drugs Can Control metastatic castration-resistant prostate cancer |
Sep-2019 |
New Frontline Combinational Therapy For Ovarian Cancer |
Sep-2019 |
A New Monoclonal Antibody Can Suppress Nipah Virus Infection |
Sep-2019 |
Afatinib A Potent Option for NRG1+ cancer Treatment |
Sep-2019 |
Ribociclib can Cross BBB in Glioblastoma Management |
Sep-2019 |
CDK 4/6 Inhibitors May Cause Severe Lung Inflammation |
Sep-2019 |
Ribociclib-Fulvestrant Combinational Therapy Can Enhance Optimum Survival |
Sep-2019 |
Abrocitinib – Pfizer’s JAK Inhibitor Successfully Clears the Crucial Eczema Study |
Sep-2019 |
CYC065 Successfully Treat an Advanced Solid Tumor Patient in Phase 1 Trial |
Sep-2019 |
Second Generation CAR-T Cell Therapy Shows Prominent Action Against Leukemia & Lymphoma |
Sep-2019 |
New Novel Drug Delivery Method using Pinpoint Targeting |
Sep-2019 |
Treatment of Chronic Diseases is Possible with Remote Control Implant |
Sep-2019 |
Synthetic Biologic System – A New Approach of Drug Delivery |
Sep-2019 |
Cancer Drug Deliver using Nanogenerator |
Sep-2019 |
TG6002 Next generation Oncolytic Virus get Approval for Clinical Trails |
Sep-2019 |
Drug Delivery can be Achieved using Swimming Microbots |
Sep-2019 |
Laser Guided Microbots shows Prominent Action in Destroying Tumor Cells |
Sep-2019 |
Drug Targeting KRAS Mutation can Acts Against Lung Cancer Treatment |
Sep-2019 |
Setmelanotide Successfully Clears Phase 3 Of Clinical Trial |
Sep-2019 |
A New Peptide Antibiotic Could Treat Tuberculosis More Effectively |
Sep-2019 |
Simvastatin – A New Approach to prevent Ischemic Damage Of Heart During Organ Transplant |
Sep-2019 |
More Accurate Drug Delivery can be Achieved with Graphene Nanoflakes |
Sep-2019 |
Targeted Drug Delivery can be Achieved by Nanoscale Glass Bottles |
Sep-2019 |
Nanoparticle Advancement Shows Promising Action Against Prostate Cancer |
Sep-2019 |
Darzalex – A New Approved Drug Combination For Multiple Myeloma |
Sep-2019 |
Phospho-specific Antibodies Are Introduced For Diagnosis |
Sep-2019 |
Newly Developed Peptide Shows Prominent Action Against Multidrug Resistant Bacteria |
Sep-2019 |
Liraglutide A Drug to Manage Pediatric Type 2 Diabetes |
Sep-2019 |
Neucardin got Fast Track Designation from US FDA for Chronic Heart Failure |
Sep-2019 |
More Accurate Drug Delivery can be Achieved with Graphene Nanoflakes |
Sep-2019 |
Erdafitinib Effective Treatment of Advanced Bladder Cancer |
Sep-2019 |
Nivolumab-Ipilimumab Combination Shows Promising Activity in Advanced RCC Confirmed |
Sep-2019 |
PD-L1 Checkpoint Inhibitors Indicates Activity against Aggressive MTC |
Sep-2019 |
CD8+ T Shows possibility in Treatment of SCLC |
Sep-2019 |
New Immunotherapy for Mesothelioma Enters in Clinical Trail |
Sep-2019 |
CRISPR An Advancement in Gene Therapy |
Sep-2019 |
Cancer Treatment with New Antibody Drug |
Sep-2019 |
Modified Macrophages Can Destroy Cancer Cells |
Sep-2019 |
Initiation of Body’s Regenerative Potential by Engineered Antibodies |
Sep-2019 |
Blend of PARP Inhibitors Shows Promising Activity against Small Cell Lung Cancer |
Sep-2019 |
Gemcitabine & Cisplatin With Enzalutamide Effectively Targets AR+ Metastatic Bladder Cancer |
Sep-2019 |
Cutaneous T-Cell Lymphoma Appears Treatable Using Antibiotics |
Sep-2019 |
Clinical Trail - Effectiveness of antibiotic in Breast Cancer |
Sep-2019 |
Nubeqa – A New Approved Treatment for Prostate Cancer |
Sep-2019 |
Stemirac – A Japanese Stem Cell Therapy for Spinal Cord Injuries |
Sep-2019 |
Dual Stem Cell Therapy shows promising action in Cardiac Regeneration |
Sep-2019 |
Immune Activating Gene Therapy for Glioblastoma Enters in Clinical Trial |
Sep-2019 |
Rapid Vaccine Delivery Can Be Achieved by Skin Patches |
Sep-2019 |
92% HPV Cancer Can Be Prevented by Vaccines |
Sep-2019 |
Personalised Cancer Vaccine in Clinical Trail Phase |
Sep-2019 |
Oral Antibiotics Increase the Risk of Colon Cancer |
Sep-2019 |
ALLO 715 - An Allogeneic CAR T Cell Therapy Moves Into Clinical Phase |
Sep-2019 |
ALLO 715 - An Allogeneic CAR T Cell Therapy Moves Into Clinical Phase |
Sep-2019 |
NEO Personalised Vaccine Shows Promising Action Against Advanced Cancers |
Sep-2019 |
T-Cell Cryopreservation - Future of Cancer Management |
Sep-2019 |
Multiple Myeloma Treatment by Synergistic Action of CAR-T Cells |
Sep-2019 |
CAR-T Cell Therapy - Major Step Towards New Therapy Approval |
Sep-2019 |
Global Orphan Therapy Clinical Pipeline Market Report Published by KuicK Research |
Apr-2017 |
Global Oncolytic Virus Therapy Market & Pipeline Report Published by KuicK Research |
Apr-2017 |
Global Cancer Immunotherapy Market Report 2022 Published by Kuick Research |
Apr-2017 |
Personalized Cancer Vaccines Market Report Published By KuicK Research |
Apr-2017 |
Global Cancer Nanomedicine Market Report Published by KuicK Research |
Apr-2017 |
NH Therapeutics receives orphan drug designation for congenital hypogonadotropic hypogonadism |
Feb-2017 |
CIRARA by Remedy Pharmaceuticals receives Orphan Drug Status |
Feb-2017 |
FDA approves SD-809 for orphan drug designation |
Dec-2016 |
Phyto-pain pharma declared the submission of orphan drug application for Delta-9-tetrahydrocannibinol & Cannabidiol |
Nov-2016 |
FDA grants orphan drug designation to Nintedanib for Systemic Sclerosis |
Oct-2016 |
Cancer Immunotherapy Pipeline Has 1834 Drugs In Clinical Trials |
Oct-2015 |
Personalized Cancer Vaccines to Transform Oncology Market L&scape |
Nov-2014 |
Orphan Drugs Show Potential With 600 Drugs in Pipeline |
Sep-2014 |
Cancer Immunotherapy Shows Potential With 1080 Drugs in Pipeline |
Sep-2014 |
South Korea Aiming to Be Global Leader In Biosimilar Development |
Sep-2014 |
Cancer Vaccines Market Emerges As Next Big Opportunity |
Sep-2014 |
Saudi Arabia Pharmaceutical Market Offers Investment Opportunity |
Sep-2014 |
Saudi Arabia Medical Device Market Offers Billion Dollar Opportunity |
Sep-2014 |
UAE Diabetes Market Offers Untapped Potential |
Sep-2014 |
Controlled Drug Release Market To Grow Exponentially |
Sep-2014 |
Cancer Immunotherapy To Supersede Traditional Treatment Methods |
Sep-2014 |
Global Intranasal Drug Market To Surpass USD 20 Billion by 2019 |
Sep-2014 |
Global Biosimilars Market Has 276 Drugs in Clinical Pipeline |
Aug-2014 |
India Cord Blood Banking Witnessing Exponential Growth |
Aug-2014 |
China Will Spend USD 700 Billion To Build Aerospace Industries |
Aug-2014 |
Controlled Release Drug Delivery Market Offers Unexplored Opportunities |
Aug-2014 |
Global COPD Drug Market To Reach USD 17 Billion by 2018 |
Aug-2014 |
Saudi Arabia Has To Rely on European Pharmaceuticals Imports |
Aug-2014 |
HIV Infection Drug Market Undergoing Clinical Transformation |
Aug-2014 |
South Korea Biosimilars Market to Reach USD 150 Million by 2018 |
Aug-2014 |
Global Radiopharmaceuticals Market USD 10 Billion Opportunity |
Aug-2014 |
Cancer Immunotherapy Market To Surpass USD 24 Billion by 2020 |
Aug-2014 |
US Cancer Vaccines Market To Maintain Its Growth Momentum |
Aug-2014 |
Europe Orphan Drug Market To Surpass USD 50 Billion by 2018 |
Aug-2014 |
HIV Vaccine Market Driven By Preclinical Research In Immunology |
Aug-2014 |
RNAi Therapy Market Dominated by Oncology Focused Drugs |
Aug-2014 |
Australia Shale Gas Industry Developments Analyzed by KuicK Research |
Aug-2014 |
India Baby Care Market To Surpass USD 2 Billion by 2018 |
Aug-2014 |
Saudi Arabia Pharmaceutical Market Witnessing Exponential Growth |
Aug-2014 |
Global Orphan Drug Market Drive by High Profitability Rate |
Aug-2014 |
Pulmonary Drug Delivery Driven By Extended Application |
Aug-2014 |
RNAi Therapy Set To Diversify Drug Delivery Mechanism |
Aug-2014 |
Immunotherapy To Transform Cancer Drug Market Dynamics |
Aug-2014 |
Antibodies Emerging As Viable Treatment for Cancers |
Aug-2014 |
COPD Drug Market to Surpass USD 17 Billion by 2018 |
Aug-2014 |
Booming India IVF Treatment Market Analyzed by KuicK Research |
Aug-2014 |
Transdermal Drug Delivery Market Opportunity Assessment Report |
Aug-2014 |
US Accounts for 50% of Global Cancer Vaccine Market |
Jul-2014 |
US Orphan Drug Market To Surpass USD 60 Billion by 2018 |
Jul-2014 |
Nanoparticle Drug Delivery Market To Treble by 2020 |
Jul-2014 |
Cancer Drugs Dominating Global Orphan Drug Market L&scape |
Jul-2014 |
Cancer Immunotherapy Offers Unexplored Market Opportunities |
Jul-2014 |
India Reverse Logistics Market Offers USD 18 Billion Opportunity |
May-2014 |
Transdermal Drug Delivery Market To Surpass USD 40 Billion By 2018 |
May-2014 |
US Cancer Vaccine Market To Surpass USD 24 Billion by 2018 |
Apr-2014 |
Global Orphan Drug Market To Surpass USD 100 Billion by 2015 |
Apr-2014 |
Radiopharmaceuticals Market to Surpass USD 10 Billion by 2018 |
Apr-2014 |
India Refurbished Medical Equipment Market To Grow Exponentially |
Apr-2014 |
Global Cell Therapy Market Witnessing Significant Growth |
Apr-2014 |
HIV Vaccine Need Driven by Focus on Prevention Of Disease |
Apr-2014 |
RNAi Therapy Emerged As Inseparable Tool In Drug Delivery |
Apr-2014 |
Cancer Remains The Key Targeted Condition For Gene Therapies |
Apr-2014 |
China Set To Dominate Global Smart Grid Spending |
Apr-2014 |
Australia Shale Gas Boom To Strengthen Its LNG Export Market |
Apr-2014 |
COPD Drug Market to Witness Exponential Growth |
Apr-2014 |
Skin Cancer Dominating US Cancer Vaccine Pipeline |
Feb-2014 |
India IVF Market To Surpass USD 4 Billion by 2018 |
Feb-2014 |
Global Orphan Drug Market to Reach USD 120 Billion by 2018 |
Feb-2014 |
UAE to Drive Gulf Defense Spending: 20% of Gulf Defense Agreements are from UAE |
Nov-2013 |
Indian IVF Treatment Market Witnessing Exponential Growth |
Nov-2013 |
Brazil Medical Device Market Offers USD 12 Billion by 2017 |
Oct-2013 |
South Korea to Emerge as Leading Biosimilar Market by 2020 |
Oct-2013 |
Saudi Arabia Pharmaceuticals Import to Surpass USD 5 Billion by 2018 |
Oct-2013 |
India E Waste Recycle Market Offers USD 1.5 Billion Opportunity |
Sep-2013 |
South Korea Government Investing in Biosimilar Market |
Aug-2013 |
Saudi Arabia Offers Billion Dollar Opportunity for Halal Cosmetics Products |
Aug-2013 |
Shale Gas To Transform China Energy Sector Dynamics |
Jul-2013 |
Indian Paint Industry to Surpass USD 10 Billion by 2017 |
Jul-2013 |
China Focusing on Domestic Development to Meet Rising Aircraft Dem& |
Jul-2013 |
South Korea Biosimilar Pipeline: 11 Biosimilars in Development Phase |
Jul-2013 |
Indian IVD Market to Double by 2016 |
Jun-2013 |
Brazil Medical Device Import to Surpass USD 9 Billion by 2018 |
Jun-2013 |
GCC Region Targeting More Than 50 GW of Solar Capacity by 2032 |
Jun-2013 |
Brazil Targeting 11 GW of Wind Capacity by 2018 |
Jun-2013 |
India as Hub for Fertility (IVF Treatment) Tourism |
Jun-2013 |
Infrastructure Investments Escalating Saudi Arabia Cement Dem& |
Jun-2013 |
Indian IVD Market Offers Abundant Expansion Opportunities |
May-2013 |
China to Drive Global Aviation Industry Business |
May-2013 |
Singapore Witnessed 250 New Clinical Trial Studies in 2012 |
May-2013 |
Russia Witnessed 900 New Clinical Trial Studies in 2012 |
May-2013 |
Middle East Drift Towards Renewable Energy |
May-2013 |
Indian Genetic Screening Market to Treble by 2018 |
May-2013 |
Indian In Vitro Diagnostics Market To Surpass USD 1 Billion by 2016 |
May-2013 |
Indian Specialty Clinics Market Emerged as Billion Dollar Opportunity |
May-2013 |
India Cord Blood Banking Market Witnessing Double Digit Growth |
May-2013 |
Indian CCTV Market to Witness Steady Conversion to IP Based Surveillance System |
May-2013 |
Solar Energy to Dominate Middle East Renewable Energy Initiatives |
Apr-2013 |
China Set to Dominate Global Aviation Industry Investment L&scape |
Apr-2013 |
UAE to Emerge as IVF Treatment Hub in Middle East Region |
Apr-2013 |
India Cosmetic Surgery Market: Untapped Billion Dollar Opportunity |
Apr-2013 |
Middle East Shifting Focus from Hydrocarbons to Renewable Energy |
Mar-2013 |
Favorable Outlook for Saudi Arabia Cement Sector |
Mar-2013 |
Genetic Testing Market in India |
Feb-2013 |
India Emerging as Sourcing Hub for Specialty Chemicals |
Feb-2013 |
Successful Bidders to Invest USD 2 Billion in Chinese Shale Blocks |
Feb-2013 |
India IVF Treatment Market to Surpass USD 2 Billion by 2014 |
Feb-2013 |
Saudi Arabia Cement Consumption to Surpass 60 MT by 2015 |
Feb-2013 |
Turkey Wind Power Installed Capacity Surpassed 2200 MW in 2012 |
Feb-2013 |
China Second Shale Gas Block Auction Results |
Jan-2013 |
Australia Leading Residential PV Systems Market |
Jan-2013 |
Research Study Highlights Solar Power Development in India |
Jan-2013 |
India Electronic Security Equipment Market To Double by 2016 |
Jan-2013 |
Significance of Renewable Energy for India |
Jan-2013 |
Turkey Targeting 20 GW Wind Capacity by 2023 |
Jan-2013 |
Projects Under State Level Policies Driving Solar Power Installations in India |
Jan-2013 |
Booming Cosmetic Surgery Market in India |
Jan-2013 |
Why GCC Region is Focusing on Renewable Energy? |
Jan-2013 |
Booming Electronic Security Equipment Market in India |
Jan-2013 |
Booming Luxury Retail Market in India |
Jan-2013 |
34 GW of Solar Power Capacity Required in India by 2022 |
Dec-2012 |
Electronic Security Equipment Market in India |
Dec-2012 |
National Solar Mission Phase II Draft Policy Released in India |
Dec-2012 |
Japan Witnessing Solar Energy Investment Boom |
Dec-2012 |
India has 25 GW of Installed Renewable Energy Capacity |
Nov-2012 |
Emerging Solar Power Sector in Australia |
Nov-2012 |
South Korea LNG Imports to Surpass 45 Million Tons in 2017 |
Nov-2012 |
Increasing Wind Power Investment from Government & Private Sector in South Korea |
Nov-2012 |
Skin Care Dominating Ayurvedic Cosmetics Market in India |
Nov-2012 |
India Cosmetic Surgery Market Outlook |
Nov-2012 |
India Has Required Policy Framework To Emerge as Leading Solar Power Market in World |
Nov-2012 |
India Targeting 20 GW of Grid Connected Solar Power by 2022 |
Nov-2012 |
Floating Solar Power Plant in Japan by 2013 |
Nov-2012 |
Government Subsidy for Shale Gas Exploration in China |
Nov-2012 |
India Targeting 53 GW Renewable Energy Capacity by 2017 |
Nov-2012 |
Booming Wind Power Capacity in South Korea |
Nov-2012 |
Wind Power in Brazil |
Nov-2012 |
China To Consume More Than 370 Bcm of Natural Gas by 2020 |
Nov-2012 |
Solar Power As Preferred Source For Clean Energy In Japan |
Oct-2012 |
Shale Gas Will Have Multi Dimensional Effects On China Energy Sector |
Oct-2012 |
More Than 1 GW of Solar Capacity Added In Australia |
Oct-2012 |
Emergence Of GCC Region As Solar Energy Investment Hub |
Oct-2012 |
India Targets To Install Over 22000 MW Of Solar Power By 2022 |
Oct-2012 |
Japan Renewable Energy Feed In Tariff Structure Favors Solar Power Development |
Oct-2012 |
Australia Solar Power Sector Outlook |
Oct-2012 |
GCC Countries To Look Beyond Oil And Gas Assets |
Oct-2012 |
South Korea Holds More Than 100 GW Of Wind Power Potential |
Oct-2012 |
Ayurvedic Cosmetics Emerged As New Growth Frontier For Beauty Business In India |
Oct-2012 |
Japan Targets 14 GW Solar Power by 2015 |
Oct-2012 |
Shale Gas Will Give Australia The Required Thrust To Dominate Global LNG Trade |
Oct-2012 |
China To Auction 20 Shale Gas Blocks In October |
Sep-2012 |
India Targets 18 GW of Renewable Energy Addition By 2017 |
Sep-2012 |
Energy From Waste Proving To Be Booming Market In India |
Sep-2012 |
South Korea To Focus On Development Of Wind Power Sector |
Sep-2012 |
Japan Emerged as Third Largest Solar Power Market in 2011 |
Sep-2012 |
Japan Added More Than 1 GW Solar Power in 2011 |
Sep-2012 |
Wind Power To Dominate South Korea Renewable Energy Efforts |
Sep-2012 |
Biosimilar Companies In India Have Edge Over Their Global Counterparts |
Sep-2012 |
India IVF Treatment Market To Witness Equity Investments & Acquisitions |
Aug-2012 |
Brazil Wind Power Capacity Grew By 80% CAGR During 2006 to 2011 |
Aug-2012 |
Diesel Engines To Fuel Indian Automobile Industry Growth Story |
Aug-2012 |
India As Biosimilar Development Hub |
Aug-2012 |
Australia Shale Gas Market Overview |
Aug-2012 |
UAE & Saudi Arabia to Drive Renewable Energy Initiatives in GCC Region |
Aug-2012 |
South Korea Wind Power Capacity Rose By 50% CAGR in Last Decade |
Aug-2012 |
GCC Renewable Energy Initiatives Offers Imense Opportunity For Solar Companies To Exp& Business Operations |
Aug-2012 |
Saudi Arabia Set Ambitious Target of Installing More Than 40 GW of Solar Power Capacity by 2032 |
Aug-2012 |
Rising Investments Indicate Unbound Future Of Australia Shale Gas Development |
Aug-2012 |
Research Study Gives Comprehensive Insight On Indian Biosimilar Market |
Aug-2012 |
China Second Shale Gas Auction Draws Phenomenal Response From Investors |
Aug-2012 |
Research Study Highlights Renewable Energy Sector Investments Opportunity in GCC Region |
Aug-2012 |
GCC Region To Focus On Solar Power To Diversify Its Energy Mix |
Aug-2012 |
Government Reforms Driving Power Sector Expansion In Brazil |
Jul-2012 |
Shale Gas Exploration & Development To Transform China Energy Sector Dynamics: KuicK Research |
Jul-2012 |
Brazil Electricity Consumption To Surpass 500 TWh by 2016 |
Jul-2012 |
Turkey Emerging As Favored Destination For Power Sector Investments |
Jul-2012 |
UAE Power Sector Offers Immense Opportunity For Private Sector Investments |
Jul-2012 |
IVF Treatment Cycles To Witness Double Digit Growth In India |
Jul-2012 |
Shale Gas Transforming Energy Sector Dynamics |
Jul-2012 |
India Sitting On Huge Waste To Energy Potential |
Jul-2012 |
Wind Power To Dominate Renewable Energy Initiatives In Brazil |
Jul-2012 |
Shale Gas Development To Strengthen Australia LNG Export Market |
Jul-2012 |
China Healthcare Expenditure Expected To Surpass US$ 450 Billion By 2014 |
Jul-2012 |
Upcoming Research Study Identifies Unexplored Shale Gas Potential In Australia |
Jun-2012 |
Turkey Wind Power Installed Capacity To Surpass 2.2 GW By 2012 |
Jun-2012 |
China To Replicate U.S Shale Gas Success Story In Coming Decade |
Jun-2012 |
Upcoming Research Report Highlights Opportunity In Shale Gas Exploration And Development In China |
Jun-2012 |
The Great Indian Dividend Converting Urban & Industrial Waste to Energy |
Jun-2012 |
Fairness Cream Sales to Dominate Male Cosmetics Market in India |
Jun-2012 |
Increasing Infertility Rate Driving IVF Treatment Market in India |
May-2012 |
Nuclear Energy To Dominate UAE Power Sector Expansion Process |
May-2012 |
Renewable Energy Set to Dominate UAE Power Sector L&scape |
Apr-2012 |
UAE Power Sector Installed Capacity Anticipated to Surpass 30 GW by 2013 |
Apr-2012 |
Turkey Wind Power Installed Capacity Grew By More Than 25% During 2011: KuicK Research |
Apr-2012 |
Indian Male Consumers Willing to Pay Premium Price for Male Specific Cosmetics Products |
Mar-2012 |
Brazil Wind Power Installed Capacity Increased by 50% During 2011: KuicK Research |
Mar-2012 |
Brazil to Emerge as Wind Power Capital of Latin America |
Mar-2012 |
Renewable Energy to Emerge as Next Growth Frontier for Turkey |
Feb-2012 |
Favorable Policy & Regulatory Framework to Drive Turkey Power Sector |
Feb-2012 |